DUX4 and facioscapulohumeral muscular dystrophy: Therapeutic strategies for FSHD focus on reducing muscular inflammation using immunomodulators, increasing muscle volume and improving muscle pathology through activation of compensatory pathways that inhibit muscle atrophy, or inhibiting DUX4 gene expression and translation using antisense oligonucleotides or gene editing techniques.